+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05830669

Study of Remote Ischemic Preconditioning to Protect Kidney Function in Critically Ill Septic Adults

Led by Universität Münster · Updated on 2024-12-12

64

Participants Needed

1

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

Acute kidney injury AKI is a common complication in critically ill patients with sepsis, and currently, there is no established drug treatment to prevent or reduce its severity. This research aims to evaluate the effects of remote ischemic preconditioning RIPC, a process involving controlled cycles of blood flow restriction to an upper limb, to protect kidneys in these patients. The study compares two groups one receiving remote ischemic preconditioning with three cycles of 5 minutes of blood pressure cuff inflation on the upper arm, possibly followed by two additional cycles of 10 minutes if needed the other group receives a sham procedure with lower cuff pressure. Treatments occur shortly after sepsis diagnosis and are monitored closely. Participants will be critically ill adults with sepsis, receiving invasive ventilation or vasopressor therapy. Researchers will monitor kidney damage using specific urinary biomarkers and assess the incidence, severity, and recovery from AKI over time. They will also track kidney function, need for dialysis, survival, and length of hospital stay up to 90 days, ensuring comprehensive safety and outcome evaluations throughout the study period.

CONDITIONS

Brief Title

Remote Ischemic Preconditioning in Septic Patients

Research Team

M

Melanie Meersch-Dini, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here